A look at equity futures shows broad declines after last week marked a second weekly gain, and coming alongside President Trump’s daily coronavirus briefing (ongoing). S&P 500 and Nasdaq futures are down by more than 0.9%, while the Dow futures are down 1%. They’re also following oil prices which
Germany will order 45 fighter jets from Boeing (NYSE:BA) to replace aging craft, Der Spiegel reports today. The country will order 30 F/A-18 Super Hornets and 15 EA-18G Growlers to replace aging Tornado jets, according to the report. The magazine said German Defense Minister Annegret Kramp-Karrenbauer mailed Defense Secretary
Summary The S&P 500 has rallied nearly 30% in just three weeks since the March lows despite the ongoing global pandemic. The environment and economic outlook remain deeply bearish for stocks which are now once again expensive and face significant downside. The market is too
Summary The S&P 500 has rallied nearly 30% in just three weeks since the March lows despite the ongoing global pandemic. The environment and economic outlook remain deeply bearish for stocks which are now once again expensive and face significant downside. The market is too
Summary A lot of people are buying USO to bet on a rebound in oil price. That’s the wrong vehicle to do it in. USO will suffer greatly in the near term due to the super contango we are seeing in the market. Cushing inventory
Summary Economic news remains very bad. The light economic calendar offers little of interest. Corporate earnings reports accelerate in the week ahead, but attention will center on the post-crisis outlook. Tracking market prospects requires a combination of science, economics, and political analysis. Only then can you
Summary This bear market has set a record in the rush to cash. Even top-quality preferred shares have felt the impact. These three picks all enjoy very strong balance sheets and substantial cash flow. They will be trading back above par before you know it.
Summary GILD surged to $84 Friday on the leak that University of Chicago Medicine’s head researcher in GILD COVID studies reported that GILD’s RDV (remdesivir) worked well. The data that Dr. Mullane reported to her colleagues suggests that RDV could be a “magic bullet,” honing